Trial intelligence / Profile preview

Topical Tacrolimus Adjunctive to Etanercept in Psoriasis

NCT00134394Phase 2Completed

Sponsor
University of Medicine and Dentistry of New Jersey
Start
Feb 2005
Modality
RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tacrolimus in psoriasis, sponsored by University of Medicine and Dentistry of New Jersey. Started Feb 2005; status: completed.

02

Drugs

tacrolimus
03

Conditions

psoriasis

Beyond the preview

Go deeper on NCT00134394.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00134394.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call